Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Background. Fluconazole (FLC) resistance is common in C. glabrata and echinocandins are often used as first-line therapy. Resistance to echinocandin therapy has been associated with FKS1 and FKS2 gene alterations. Methods. We reviewed records of all patients with C. glabrata bloodstream infection at...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Alexander, Barbara D., Johnson, Melissa D., Pfeiffer, Christopher D., Jiménez-Ortigosa, Cristina, Catania, Jelena, Booker, Rachel, Castanheira, Mariana, Messer, Shawn A., Perlin, David S., Pfaller, Michael A.
Format: Artigo
Język:Inglês
Wydane: Oxford University Press 2013
Hasła przedmiotowe:
Articles and Commentaries
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3658363/
https://ncbi.nlm.nih.gov/pubmed/23487382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cit136
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy